Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with ...

Mount Carmel’s heart and vascular teams have debuted several new, highly advanced surgical procedures in Central Ohio.

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating ...

A mum living with a rare disease has said she is “waiting by the phone” for the news a life-saving lung donor has been found.

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Merck (MRK) announced the Phase 3 HYPERION study evaluating WINREVAIR versus placebo in recently diagnosed adults with pulmonary arterial ...